Skip to main content
. 2004 Dec;102:233–250.

Table 9.

Structural outcome at nine months for infants with bilateral high-risk prethreshold retinopathy of prematurity by icrop category and rm-rop2 risk*

Icrop classification
Discordant pairs
Zone Stage Plus disease Eyes treated at high-risk prethreshold Conventionally managed eyes A B
I 3 Yes or No 27 (29.6) 27 (55.6) 8 1
I 1 or 2 Yes 9 (22.2) 9 (22.2) 0 0
I 1 or 2 No 75 (2.7) 75 (9.3) 6 1
II 3 Yes 109 (7.3) 110 (10.9) 6 3
II 3 No 3 (0) 3 (0) 0 0
II 2 Yes 34 (20.6) 34 (20.6) 1 1
RM-ROP2 risk
0.15 to <0.30 109 (5.5) 109 (7.3) 4 2
0.30 to <0.45 74 (9.5) 74 (17.6) 7 1
0.45 81 (18.5) 82(30.5) 12 3

ICROP, International Classification of Retinopathy of Prematurity20; RM-ROP2,7 a risk analysis program based on natural history data from the Multicenter Trial of Cryotherapy for Retinopathy of Prematurity Study.

*

Data are presented as number (percentage unfavorable) unless otherwise indicated. High risk was 0.15 or greater. Plus disease was defined as a degree of dilation and tortuosity of the posterior retinal blood vessels meeting or exceeding that of a standard photograph. Data include only those eyes for which structural outcome was able to be graded.

For group A, earlier treated eyes had a favorable outcome, and conventionally managed eyes had an unfavorable outcome.

For group B, earlier treated eyes had an unfavorable outcome, and conventionally managed eyes had a favorable outcome.